RLBGX
Price
$36.98
Change
+$0.10 (+0.27%)
Updated
Jul 10 closing price
Net Assets
252.22B
VWENX
Price
$78.50
Change
+$0.17 (+0.22%)
Updated
Jul 10 closing price
Net Assets
114.7B
Interact to see
Advertisement

RLBGX vs VWENX

Header iconRLBGX vs VWENX Comparison
Open Charts RLBGX vs VWENXBanner chart's image
American Funds American Balanced R6
Price$36.98
Change+$0.10 (+0.27%)
VolumeN/A
Net Assets252.22B
Vanguard Wellington™ Admiral™
Price$78.50
Change+$0.17 (+0.22%)
VolumeN/A
Net Assets114.7B
RLBGX vs VWENX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RLBGX vs. VWENX commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLBGX is a Buy and VWENX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 252B vs. VWENX (115B). RLBGX (2.15) and VWENX (2.09) have matching dividends . RLBGX was incepted earlier than VWENX: RLBGX (16 years) vs VWENX (24 years). RLBGX (0.25) is less costly to investors than VWENX (0.17). VWENX is a more actively managed with annual turnover of: 61.00 vs. RLBGX (44.00). RLBGX has a lower initial minimum investment than VWENX: RLBGX (250) vs VWENX (50000). RLBGX annual gain was more profitable for investors over the last year : 7.43 vs. VWENX (1.46). RLBGX return over 5 years is better than : 42.59 vs. VWENX (13.44).
RLBGXVWENXRLBGX / VWENX
Total Expense Ratio0.250.17147%
Annual Report Gross Expense Ratio0.250.17147%
Fund Existence16 years24 years-
Gain YTD8.4946.696127%
Front LoadN/AN/A-
Min. Initial Investment250500001%
Min. Initial Investment IRAN/AN/A-
Net Assets252B115B219%
Annual Yield % from dividends2.152.09102%
Returns for 1 year7.431.46509%
Returns for 3 years37.0815.57238%
Returns for 5 years42.5913.44317%
Returns for 10 years67.4128.37238%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCDA2.420.06
+2.54%
BioCardia Inc.
CRI33.110.64
+1.97%
Carter's
MKC72.440.23
+0.32%
McCormick & Company
PHAR10.00-0.01
-0.10%
Pharming Group NV
KRRO13.59-1.13
-7.68%
Korro Bio